Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 22% ± 6% | |
oligodendrocyte | 8 studies | 28% ± 10% | |
adipocyte | 7 studies | 23% ± 6% | |
astrocyte | 7 studies | 32% ± 13% | |
oligodendrocyte precursor cell | 6 studies | 34% ± 15% | |
GABAergic neuron | 5 studies | 42% ± 18% | |
interneuron | 5 studies | 35% ± 22% | |
epithelial cell | 4 studies | 23% ± 2% | |
glutamatergic neuron | 4 studies | 57% ± 19% | |
endothelial cell of lymphatic vessel | 4 studies | 17% ± 1% | |
fibroblast | 4 studies | 20% ± 3% | |
ciliated cell | 3 studies | 17% ± 2% | |
hepatocyte | 3 studies | 36% ± 12% | |
neuron | 3 studies | 38% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1223.86 | 459 / 459 | 100% | 12.52 | 1118 / 1118 |
esophagus | 100% | 867.97 | 1445 / 1445 | 100% | 12.17 | 183 / 183 |
pancreas | 100% | 791.42 | 328 / 328 | 100% | 7.16 | 178 / 178 |
prostate | 100% | 1325.98 | 245 / 245 | 100% | 15.55 | 502 / 502 |
thymus | 100% | 1401.05 | 653 / 653 | 100% | 10.54 | 605 / 605 |
ovary | 100% | 1492.53 | 180 / 180 | 100% | 9.65 | 429 / 430 |
brain | 100% | 732.84 | 2637 / 2642 | 100% | 9.35 | 704 / 705 |
lung | 100% | 828.53 | 576 / 578 | 100% | 10.46 | 1155 / 1155 |
uterus | 100% | 1585.51 | 170 / 170 | 100% | 10.30 | 457 / 459 |
liver | 100% | 1089.07 | 226 / 226 | 100% | 7.46 | 404 / 406 |
kidney | 100% | 1011.22 | 89 / 89 | 99% | 9.63 | 892 / 901 |
bladder | 100% | 930.81 | 21 / 21 | 98% | 8.36 | 496 / 504 |
stomach | 100% | 763.32 | 359 / 359 | 98% | 8.84 | 279 / 286 |
adrenal gland | 100% | 988.23 | 258 / 258 | 97% | 7.82 | 224 / 230 |
intestine | 100% | 989.36 | 966 / 966 | 97% | 7.98 | 510 / 527 |
skin | 100% | 976.35 | 1809 / 1809 | 95% | 10.15 | 449 / 472 |
adipose | 100% | 1091.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.75 | 29 / 29 |
muscle | 100% | 1769.10 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1019.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.56 | 1 / 1 |
blood vessel | 100% | 976.15 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 648.90 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 7.06 | 72 / 80 |
peripheral blood | 50% | 414.13 | 463 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0071008 | Cellular component | U2-type post-mRNA release spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GCFC2 |
Protein name | Intron Large complex component GCFC2 (GC-rich sequence DNA-binding factor) (GC-rich sequence DNA-binding factor 2) (Transcription factor 9) (TCF-9) GC-rich sequence DNA-binding factor 2 |
Synonyms | C2orf3 GCF TCF9 |
Description | FUNCTION: Involved in pre-mRNA splicing through regulating spliceosome C complex formation . May play a role during late-stage splicing events and turnover of excised introns . . |
Accessions | ENST00000409857.7 [P16383-2] H7C335 S4R465 ENST00000321027.8 [P16383-1] P16383 S4R461 ENST00000470285.1 ENST00000470503.1 [P16383-3] S4R3C1 ENST00000442309.5 ENST00000472230.5 ENST00000427862.1 ENST00000541687.5 [P16383-4] C9JII4 ENST00000492826.1 |